IP Policy for Business Moves on to Final Step
Call it the 25 percent conundrum. Or the payback puzzle.
That was one key issue facing the Intellectual Property Task Force of the California stem cell agency during its meeting Thursday on IP policy for grants to businesses.
Specifically, when do businesses have to come up with plans for access to CIRM-financed therapies, making them available to the u…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.